Abstract
Platelet activation and blood coagulation are reciprocal processes, both contributing to hemostasis and thrombosis in an interactive way. Exposed collagen, von Willebrand factor (VWF), and other components of the subendothelial matrix initiate platelet adhesion, whereas exposed tissue factor simultaneously triggers the coagulation cascade. During the various phases of the coagulation process, activated platelets support and steer coagulation by at least four mechanisms, namely, by (1) exposing the procoagulant phospholipid phosphatidylserine (PS) at their outer surface; (2) releasing coagulation factors like factors V and XIII, as well as anticoagulant factors like tissue factor pathway inhibitor; (3) providing a scaffold for the formation of fibrin fibers; and (4) stimulating retraction of the fibrin clot. In this chapter, we describe these roles of platelets in detail, also focusing on the receptors and signaling pathways involved and on the distinct (anti)coagulant pathways.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Agbani EO, van den Bosch MT, Brown E, Williams CM, Mattheij NJ, Cosemans JM, Collins PW, Heemskerk JW, Hers I, Poole AW (2015) Coordinated membrane ballooning and procoagulant spreading in human platelets. Circulation 132:1414–1424
Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL (2000) Surface expression and functional characterization of α-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood 95:1694–1702
Alshehri OM, Hughes CE, Montague S, Watson SK, Frampton J, Bender M, Watson SP (2015) Fibrin activates GPVI in human and mouse platelets. Blood 126:1601–1608
Al-Tamimi M, Grigoriadis G, Tran H, Paul E, Servadei P, Berndt MC, Gardiner EE, Andrews RK (2011) Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa. Blood 117:3912–3920
Andersen H, Greenberg DL, Fujikawa K, Xu WF, Chung DW, Davie EW (1999) Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity. Proc Natl Acad Sci U S A 96:11189–11193
Andrews RK, Karunakaran D, Gardiner EE, Berndt MC (2007) Platelet receptor proteolysis. A mechanism for downregulating platelet reactivity. Arterioscler Thromb Vasc Biol 27:1511–1520
Auger JM, Watson SP (2008) Dynamic tyrosine kinase-regulated signaling and actin polymerisation mediate aggregate stability under shear. Arterioscler Thromb Vasc Biol 28:1499–1504
Baglia FA, Shrimpton CN, Emsley J, Kitagawa K, Ruggeri ZM, Lopez JA, Walsh PN (2004) Factor XI interacts with the leucine-rich repeats of glycoprotein Ibα on the activated platelet. J Biol Chem 279:49323–49329
Béguin S, Kumar R (1997) Thrombin, fibrin and platelets, a resonance loop in which von Willebrand factor is a necessary link. Thromb Haemost 78:590–594
Béguin S, Kumar R, Keularts I, Seligsohn U, Coller BS, Hemker HC (1999) Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood 93:564–570
Bender M, Hofmann S, Stegner D, Chalaris A, Bösl M, Braun A, Scheller J, Rose-John S, Nieswandt B (2010) Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. Blood 116:3347–3355
Bergmeier W, Chauhan AK, Wagner DD (2008) Glycoprotein Ibα and von Willebrand factor in primary platelet adhesion and thrombus formation: lessons from mice. Thromb Haemost 99:264–270
Berny MA, Munnix IC, Auger JM, Schols SE, Cosemans JM, Panizzi P, Bock PE, Watson SP, McCarty OJ, Heemskerk JW (2010) Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear. PLoS One 5, e10415
Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64–67
Bevers EM, Comfurius P, Zwaal RF (1991) Platelet procoagulant activity, physiological significance and mechanisms of exposure. Blood Rev 5:146–154
Bouchard BA, Williams JL, Meisler NT, Long MW, Tracy PB (2005) Endocytosis of plasma-derived factor V by megakaryocytes occurs via a clathrin-dependent, specific membrane binding event. J Thromb Haemost 3:541–551
Boulaftali Y, Ho-Tin-Noe B, Pena A, Loyau S, Venisse L, Francois D, Richard B, Arocas V, Collet JP, Jandrot-Perrus M, Bouton MC (2011) Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis. Circulation 12:1326–1334
Brambilla M, Facchinetti L, Canzano P, Rossetti L, Ferri N, Balduini A, Abbonante V, Boselli D, De Marco L, Di Minno MN, Toschi V, Corsini A, Tremoli E, Camera M (2015) Human megakaryocytes confer tissue factor to a subset of shed platelets to stimulate thrombin generation. Thromb Haemost 114:579–592
Burkhart JM, Vaudel M, Gambaryan S, Radau S, Walter U, Martens L, Geiger J, Sickmann A, Zahedi RP (2012) The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 120:e73–e82
Burkhart JM, Gambaryan S, Watson SP, Jurk K, Walter U, Sickmann A, Heemskerk JW, Zahedi RP (2014) What can proteomics tell us about platelets? Circ Res 114:1204–1219
Canobbio I, Balduini C, Torti M (2004) Signalling through the platelet glycoprotein Ib-V-IX complex. Cell Signal 16:1329–1344
Cheng Q, Tucker EI, Pine MS, Sisler I, Matafonov A, Sun MF, White-Adams TC, Smith SA, Hanson SR, McCarty OJT, Renné T, Gruber A, Gailani D (2010) A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Blood 116:3981–3989
Cho J, Furie BC, Coughlin SR, Furie B (2008) A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest 118:1123–1131
Choi SH, Smith SA, Morissey JH (2011) Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood 118:6963–6970
Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, Cahill DJ, Emili A, Fitzgerald DJ, Maguire PB (2004) Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103:2096–2104
Cosemans JM, Iserbyt BF, Deckmyn H, Heemskerk JW (2008) Multiple pathways to switch platelet integrins on and off. J Thromb Haemost 6:1253–1261
Cosemans JM, Schols SE, Stefanini L, de Witt S, Feijge MA, Hamulyak K, Deckmyn H, Bergmeier W, Heemskerk JW (2011) Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow. Blood 117:651–660
Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258–264
Coughlin SR (2005) Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3:1800–1814
Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, Clemetson KJ, Alberio L (2002) Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 415:175–179
Daubie V, Cauwenberghs S, Senden NH, Pochet R, Lindhout T, Buurman WA, Heemskerk JW (2006) Factor Xa and thrombin evoke additive calcium and proinflammatory responses in endothelial cells subjected to coagulation. Biochim Biophys Acta 1763:860–869
De Bosch NB, Mosesson MW, Ruiz-Sáez A, Echenagucia M, Rodriguez-Lemoin A, Thrompson-Montgomery D (2002) Inhibition of thrombin generation in plasma by fibrin formation (antithrombin I). Thromb Haemost 88:253–258
De Candia E, Hall SW, Rutella S, Landolfi R, Andrews RK, de Cristofaro R (2001) Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of PAR-1 on intact platelets. J Biol Chem 276:4692–4698
De Witt S, Verdoold R, Cosemans JM, Heemskerk JW (2014a) Insights into platelet-based control of coagulation. Thromb Res 133:S139–S148
De Witt SM, Lamers MM, Swieringa F, van Kruchten R, Mastenbroek T, Coort S, Cavill R, Pugh N, Farndale RW, Clemetson KJ, Heemskerk JW, Cosemans JM (2014b) Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat Commun 5:4257
Dejouvencel T, Doeuvre L, Lacroix R, Plawinski L, Dignat-George F, Lijnen HR, Anglés-Cano E (2010) Fibrinolytic cross-talk: a new mechanism for plasmin formation. Blood 115:2048–2056
Dhanjal TS, Ross EA, Auger JM, McCarty OW, Hughes CE, Senis YA, Watson SP (2007) Minimal regulation of platelet activation by PECAM-1. Platelets 18:56–67
Dorsam RT, Tuluc M, Kunapuli SP (2004) Role of protease-activated and ADP receptor subtypes in thrombin generation on human platelets. J Thromb Haemost 2:804–812
Dubois C, Panicot-Dubois L, Gainor JF, Furie BC, Furie B (2007) Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation, a laser injury model. J Clin Invest 117:953–960
Fager AM, Wood JP, Bouchard BA, Feng P, Tracy PB (2010) Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase. Arterioscler Thromb Vasc Biol 30:2400–2407
Frelinger AL, Jakubowski JA, Li Y, Barnard MR, Linden MD, Rarnow I, Fox ML, Sugidachi A, Winters KJ, Furman MI, Michelson AD (2008) The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities. J Thromb Haemost 6:359–365
Friedman EA, Ogletree ML, Haddad EV, Boutaud O (2015) Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease. Thromb Res 136:493–503
Fukuda T, Tsuji N, Honda Y, Kamisato C, Morishima Y, Shibano T (2011) Comparison of antithrombotic efficacy between edoxaban, a direct factor Xa inhibitor, and fondaparinux, an indirect factor Xa inhibitor under low and high shear rates. Thromb Haemost 106:1062–1068
Furie B, Furie BC (2005) Thrombus formation in vivo. J Clin Invest 115:3355–3362
Giesen PL, Rauch U, Bohrman B, Kling D, Roqué M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y (1999) Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 96:2311–2315
Gilio K, van Kruchten R, Braun A, Berna-Erro A, Feijge MA, Stegner D, van der Meijden PE, Kuijpers MJ, Varga-Szabo D, Heemskerk JW, Nieswandt B (2010) Roles of STIM1 and Orai1 in glycoprotein VI- and thrombin-dependent procoagulant activity and thrombus formation. J Biol Chem 285:23629–23638
Girard TJ, Tuley E, Broze GJ (2012) TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsome. Blood 119:1256–1262
Girolami A, de Marinis GB, Bonamigo E, Lombardi AM (2012) Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias. Haematology 17:346–349
Goschnick MW, Lau LM, Wee JL, Liu YS, Hogarth PM, Robb LM, Hickey MJ, Wright MD, Jackson DE (2006) Impaired outside-in integrin αIIbβ3 signaling and thrombus stability in TSSC6-deficient mice. Blood 108:1911–1918
Gould WR, Silveira JR, Tracy PB (2004) Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor. J Biol Chem 279:2383–2393
Hackeng TM, Sere KM, Tans G, Rosing J (2006) Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci U S A 103:3106–3111
Hall SW, Humphries JE, Gonias SL (1991) Inhibition of cell surface receptor-bound plasmin by α2-antiplasmin and α2-macroglobulin. J Biol Chem 266:12329–12336
Hardy AR, Jones ML, Mundell SJ, Poole AW (2004) Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets. Blood 104:1745–1752
Harper MT, Camacho-Londono JE, Quick K, Camacho-Londono J, Flockerzi V, Phillipp SE, Birnbaumer L, Freichei M, Poole AW (2013) Transient receptor potential channels function as a coincidence signal mediating phosphatidylserine exposure. Sci Signal 6:ra50
Heemskerk JW, Feijge MA, Henneman L, Rosing J, Hemker HC (1997a) The Ca2+-mobilizing potency of α-thrombin and thrombin-receptor-activating peptide on human platelets. Concentration and time effects of thrombin-induced Ca2+ signaling. Eur J Biochem 249:547–555
Heemskerk JW, Vuist WM, Feijge MA, Reutelingsperger CP, Lindhout T (1997b) Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine and procoagulant activity of adherent platelets. Evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses. Blood 90:2615–2625
Heemskerk JW, Willems GM, Rook MB, Sage SO (2001) Ragged spiking in free calcium in ADP-stimulated platelets: regulation of puff-like calcium signal in vitro and ex vivo. J Physiol 535:625–635
Heemskerk JW, Bevers EM, Lindhout T (2002) Platelet activation and blood coagulation. Thromb Haemost 88:186–193
Heemskerk JW, Mattheij N, Cosemans JM (2013) Platelet-based coagulation: different populations, different functions. J Thromb Haemost 11:2–11
Hoffman M, Volovyk Z, Persson E, Gabriel DA, Ezban M, Monroe DM (2011) Platelet binding and activity of a factor VIIa variant with enhanced tissue factor independent activity. J Thromb Haemost 9:759–766
Ivanciu L, Krishnaswamy S, Camire RM (2014) New insights into the spatiotemporal localization of prothrombinase in vivo. Blood 124:1705–1714
Jackson SP (2011) Arterial thrombosis: insidious, unpredictable and deadly. Nat Med 17:1423–1436
Jackson SP, Schoenwaelder SM (2010) Procoagulant platelets—are they necrotic? Blood 116:2011–2018
Jasuja R, Passam FH, Kennedy DR, Kim SH, van Hessem L, Lin L, Bowley SR, Joshi SS, Dilks JR, Furie B, Furie BC, Flaumenhaft R (2012) Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents. J Clin Invest 122:2104–2113
Jobe SM, Leo L, Eastvold JS, Dickneite G, Ratliff TL, Lentz SR, Di Paola J (2005) Role of FcRγ and factor XIIIa in coated platelet formation. Blood 106:4146–4151
Jones CI, Sage T, Moraes LA, Vaiyapuri S, Hussain U, Tucker KL, Barrett NE, Gibbins JM (2014) Platelet endothelial cell adhesion molecule-1 inhibits platelet response to thrombin and von Willebrand factor by regulating the internalization of glycoprotein Ib via Akt/glycogen synthase kinase-3/dynamin and integrin αIIbβ3. Arterioscler Thromb Vasc Biol 34:1968–1976
Judge HM, Buckland RJ, Sugidachi A, Jakubowski JA, Storey RF (2008) The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory reactions. Platelets 19:125–133
Jurk K, Lahav J, Van Aken H, Brodde MF, Nofer JR, Kehrel BE (2011) Extracellular protein disulfide isomerase regulates feedback activation of platelet thrombin generation via modulation of coagulation factor binding. J Thromb Haemost 9:2278–2290
Kalia N, Auger JM, Atkinson B, Watson SP (2008) Critical role of FcR γ-chain, LAT, PLCγ2 and thrombin in arteriolar thrombus formation upon mild, laser-induced endothelial injury in vivo. Microcirculation 15:325–335
Karshovska E, Zhao Z, Blanchet X, Schmitt MM, Bidzhekov K, Soehnlein O, von Hundelshausen P, Mattheij NJ, Cosemans JM, Megens RT, Koeppel TA, Schober A, Hackeng TM, Weber C, Koenen RR (2015) Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice. Circ Res 116:587–599
Kasahara K, Souri M, Kaneda M, Miki T, Yamamoto N, Ichinose A (2010) Impaired clot retraction in factor XIII A subunit-deficient mice. Blood 115:1277–1279
Keuren JF, Wielders SJ, Ulrichts H, Hackeng T, Deckmyn H, Heemskerk JW, Bevers E, Lindhout T (2005) Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through protease-activated receptor-1. Arterioscler Thromb Vasc Biol 25:1499–1505
Kleinschnitz C, Stoll G, Bendszus M, Schuh K, Pauer HU, Burfeind P, Renné C, Gailani D, Nieswandt B, Renné T (2006) Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J Exp Med 203:513–518
Kmit A, van Kruchten R, Ousingsawat J, Mattheij NJ, Senden-Gijsbers B, Heemskerk JW, Scheiber R, Bevers EM, Kunzelmann K (2013) Calcium-activated and apoptotic phospholipid scrambling induced by Ano6 can occur independently of Ano6 ion currents. Cell Death Dis 4, e611
Kuijpers MJ, Nieuwenhuys CM, Feijge MA, Kloots W, Giesen PL, Jerling JC, oude Egbrink MG, Heemskerk JW (2005) Regulation of tissue factor-induced coagulation and platelet aggregation in flowing whole blood. Thromb Haemost 93:97–105
Kuijpers MJ, Munnix IC, Cosemans JM, van Vlijmen BJ, Reutelingsperger CP, oude Egbrink MG, Heemskerk JW (2008) Key role of platelet procoagulant activity in tissue factor- and collagen-dependent thrombus formation in arterioles and venules in vivo. Differential sensitivity to thrombin inhibition. Microcirculation 15:269–282
Kuijpers MJ, van der Meijden PE, Feijge MA, Mattheij NJ, May F, Govers-Riemslag J, Meijers JC, Heemskerk JW, Renné T, Cosemans JM (2014) Factor XIIa regulates the pathological process of thrombus formation on ruptured plaques. Arterioscler Thromb Vasc Biol 34:1674–1680
Lahav J, Wijnen EM, Hess O, Hamaia SW, Griffiths D, Makris M, Knight CG, Essex DW, Farndale RW (2003) Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin α2β1. Blood 102:2085–2092
Larsson M, Rayzman V, Nolte MW, Nickel KF, Björkqvist J, Jämsä A, Hardy MP, Fries M, Schmidbauer S, Hedenqvist P, Broomé M, Pragst I, Dickneite G, Wilson MJ, Nash AD, Panousis C, Renné T (2014) A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk. Sci Transl Med 6:222ra217
Lau LM, Wee JL, Wright MD, Moseley GW, Hogarth PM, Ashman LK, Jackson DE (2004) The tetraspanin superfamily member CD151 regulates outside-in integrin αIIbβ3 signaling and platelet activation. Blood 104:2368–2375
Lecut C, Schoolmeester A, Kuijpers MJ, Broers JL, van Zandvoort MA, Vanhoorelbeke K, Deckmyn H, Jandrot-Perrus M, Heemskerk JW (2004) Principal role of glycoprotein VI in α2β1 and αIIbβ3 activation during collagen-induced thrombus formation. Arterioscler Thromb Vasc Biol 24:1727–1733
Lee H, Sturgeon SA, Jackson SP, Hamilton JR (2012) The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions. Thromb Haemost 107:328–337
Lhermusier T, van Rottem J, Garcia C, Xuereb JM, Ragab A, Martin V, Gratacap MP, Sie P, Payrastre B (2011) The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies. Thromb Haemost 9:2067–2076
Li W, Johnson D, Esmon CT, Huntington JA (2004) Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol 11:857–862
Lisman T, Moschatsis S, Adelmeijer J, Nieuwenhuis HK, de Groot PG (2003) Recombinant factor VIIa enhances deposition of platelets with congenital or acquired αIIbβ3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation. Blood 101(5):1864–1870
London FS, Marcinkiewicz M, Walsh PN (2006) PAR1-stimulated factor IXa binding to a small platelet subpopulation requires a pronounced and sustained increase of cytoplasmic calcium. Biochemistry 45:7289–7298
Mackman N (2008) Triggers, targets and treatments for thrombosis. Nature 451:914–918
Magwenzi SG, Ajjan RA, Standeven KF, Parapia LA, Naseem KM (2011) Factor XIII supports platelet activation and enhances thrombus formation by matrix proteins under flow conditions. J Thromb Haemost 9:820–833
Majumder R, Quinn-Allen MA, Kane WH, Lentz BR (2008) A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex. Blood 112:2795–2802
Makkawi M, Moheimani F, Alserihi R, Howells D, Wright M, Ashman L, Jackson DE (2015) A complementary role for tetraspanin superfamily member CD151 and ADP purinergic P2Y12 receptor in platelets. Thromb Haemost 114:1004–1019
Mammadova-Bach E, Ollivier V, Loyau S, Schaff M, Dumont B, Favier R, Freyburger G, Latger-Cannard V, Nieswandt B, Gachet C, Mangin P, Jandrot-Perrus M (2015) Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation. Blood 126:683–691
Maroney SA, Haberichter SL, Friese P, Collins ML, Ferrel JP, Dale GL, Mast AE (2007) Active tissue factor pathway inhibitor is expressed on the surface of coated platelets. Blood 109:1931–1937
Maroney SA, Cooley BC, Ferrel JP, Bonesho CE, Mast AE (2011) Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth. Arterioscler Thromb Vasc Biol 31:821–826
Martin V, Guillermet-Guibert J, Chicanne G, Cabou C, Jandrot-Perrus M, Plantavid M, Vanhaesebroeck B, Payrastre B, Gratacap MP (2010) Deletion of the p110b isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo. Blood 115:2008–2013
Mastenbroek TG, van Geffen JP, Heemskerk JW, Cosemans JM (2015) Acute and persistent platelet and coagulant activities in atherothrombosis. J Thromb Haemost 13(Suppl 1):S272–S280
Mattheij NJ, Gilio K, Van Kruchten R, Jobe SM, Wieschhaus AJ, Chishti AH, Collins P, Heemskerk JW, Cosemans JM (2013) Dual mechanism of integrin αIIbβ3 closure in procoagulant platelets. J Biol Chem 288:13325–13336
Mattheij NJ, Berny-Lang MA, van de Vijver P, Hackeng T, McCarty OJ, Cosemans JM, Heemskerk JW (2016a) Functional characteristics of coated platelets. Haematologica 101:427–436
Mattheij NJ, Braun A, van Kruchten R, Castoldi E, Pircher J, Baaten CC, Wülling M, Kuijpers MJ, Köhler R, Poole AW, Schreiber R, Vortkamp A, Collins PW, Nieswandt B, Kunzelmann K, Cosemans JM, Heemskerk JW (2016b) Survival protein anoctamin-6 controls multiple platelet responses including phospholipid scrambling, swelling and protein cleavage. FASEB J 30:727–737
May F, Hagedorn I, Pleines I, Bender M, Vögtle T, Eble J, Elvers M, Nieswandt B (2009) CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis. Blood 114:3464–3472
Miles LA, Plow EF (1985) Binding and activation of plasminogen on the platelet surface. J Biol Chem 260:4303–4311
Miles LA, Plow EF, Waisman DM, Parmer RJ (2012) Plasminogen receptors. J Biomed Biotechnol 2012:130735
Misceo D, Holmgren A, Louch WE, Holme PA, Mizobuchi M, Morales RJ, De Paula AM, Stray-Pedersen A, Lyle R, Dalhus B, Christensen G, Stormorken H, Tjonnfjord GE, Frengen E (2014) A dominant STIM1 mutation causes Stormorken syndrome. Hum Mutat 35:556–564
Miszta A, Pelkmans L, Lindhout T, Krishnamoorthy G, de Groot PG, Hemker HC, Heemskerk JW, Kelchtermans H, de Laat B (2014) Thrombin-dependent incorporation of von Willebrand factor into a fibrin network. J Biol Chem 289:35979–35986
Mitchell JL, Lionikiene AS, Fraser SF, Whyte CS, Booth NA, Mutch NJ (2014) Functional factor XIII-A is exposed on the stimulated platelet surface. Blood 124:3982–3990
Monroe DM, Hoffman M (2006) What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol 26:41–48
Monroe DM, Hoffman M, Roberts HR (2002) Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 22:1381–1389
Moroi M, Jung SM, Okuma M, Shinmyozu K (1989) A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 84:1440–1445
Mosnier LO, Buijtenhuijs P, Marx PF, Meijers JC, Bouma BN (2003) Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets. Blood 101:4844–4846
Müller I, Klocke A, Alex M, Kotzsch M, Luther T, Morgenstern E, Zieseniss S, Zahler S, Preissner K, Engelmann B (2003) Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J 17:476–478
Müller F, Mutch NJ, Schenk WA, Smith SA, Esterl L, Spronk HM, Schmidbauer S, Gahl WA, Morrissey JH, Renné T (2009) Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 139:1143–1156
Munnix IC, Strehl A, Kuijpers MJ, Auger JM, van der Meijden PE, van Zandvoort MA, oude Egbrink M, Nieswandt B, Heemskerk JW (2005) The glycoprotein VI-phospholipase Cγ2 signaling pathway controls thrombus formation induced by collagen and tissue factor in vitro and in vivo. Arterioscler Thromb Vasc Biol 25:2673–2678
Munnix IC, Kuijpers MJ, Auger JM, Thomassen CM, Panizzi P, van Zandvoort MA, Rosing J, Bock PE, Watson SP, Heemskerk JW (2007) Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation. Regulation by transient integrin activation. Arterioscler Thromb Vasc Biol 27:2484–2490
Munnix IC, Gilio K, Siljander PR, Raynal N, Hackeng T, Feijge MA, Deckmyn H, Farndale RW, Heemskerk JW (2008) Affinity modulation of triple-helical peptides for binding to integrin α2β1 and glycoprotein VI affects thrombus formation under flow: a study with collagen-mimicking peptides. J Thromb Haemost 7:2132–2142
Munnix IC, Cosemans JM, Auger JM, Heemskerk JW (2009) Platelet response heterogeneity in thrombus formation. Thromb Haemost 102:1149–1156
Naik MU, Stalker TJ, Brass LF, Naik UP (2012) JAM-A protects from thrombosis by suppressing integrin αIIbβ3-dependent outside-in signaling in platelets. Blood 119:3352–3360
Nergiz-Unal R, Cosemans JM, Feijge MA, van der Meijden PE, Storey RF, van Giezen JJJ, oude Egbrink MG, Heemskerk JW, Kuijpers MJ (2010) Stabilizing role of platelet P2Y12 receptors in shear-dependent thrombus formation on ruptured plaques. PLoS One 5:e10130
Nergiz-Unal R, Lamers MM, van Kruchten R, Luiken JJ, Cosemans JM, Glatz JF, Kuijpers MJ, Heemskerk JW (2011) Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low density lipoprotein. J Thromb Haemost 9:1835–1846
Nieswandt B, Watson SP (2003) Platelet-collagen interaction: is GPVI the central receptor? Blood 102:449–461
Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mohtari-Nejad R, Lindhout T, Heemskerk JW, Zirngibl H, Fässler R (2001) Glycoprotein VI but not α2β1 integrin is essential for platelet interaction with collagen. EMBO J 20:2120–2130
Nurden AT, Nurden P (2014) Congenital platelet disorders and understanding of platelet function. Br J Haematol 165:165–178
Obergfell A, Eto K, Mocsai A, Buensuceso C, Moores SL, Brugge JS, Lowell CA, Shattil SJ (2002) Coordinate interactions of Csk, Src, and Syk kinases with αIIbβ3 initiate integrin signaling to the cytoskeleton. J Cell Biol 157:265–275
Offermanns S (2006) Activation of platelet function through G protein-coupled receptors. Circ Res 99:1293–1304
Okorie UM, Denney WS, Chatterjee MS, Neeves KB, Diamond SL (2008) Determination of tissue factor thresholds that trigger coagulation versus venous and arterial shear rates: amplification of 100 f. circulating tissue factor requires flow. Blood 111:3507–3513
Ono A, Westein E, Hsiao S, Nesbitt WS, Hamilton JR, Schoenwaelder SM, Jackson SP (2008) Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth. Blood 112:90–99
Panes O, Matus V, Saez CG, Quiroga T, Pereira J, Mezzano D (2007) Human platelets synthesize and express tissue factor. Blood 109:5242–5250
Petrucci G, De Cristofaro R, Rutella S, Ranelletti FO, Pocaterra D, Lancellotti S, Habib A, Patrono C, Rocca B (2011) Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors. J Pharmacol Exp Ther 336:391–402
Podrez EA, Byzova TV, Febbraio M, Salomon RG, Ma YQ, Valiyaveettil M, Poliakov E, Sun M, Finton PJ, Curtis BR, Chen J, Zhang R, Silverstein RL, Hazen SL (2007) Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med 13:1086–1095
Pollitt AY, Grygielska B, Leblond B, Désiré L, Eble JA, Watson SP (2010) Phosphorylation of CLEC-2 is dependent on lipid rafts, actin polymerization, secondary mediators, and Rac. Blood 115:2938–2946
Quinton TM, Kim S, Derian CK, Jin J, Kunapuli SP (2004) Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4. J Biol Chem 279:18434–18439
Reed GL, Matsueda GR, Haber E (1992) Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of α2-antiplasmin to fibrin. Thromb Haemost 68:315–320
Revenko AS, Gao D, Crosby JR, Bhattacharjee G, Zhao C, May C, Gailani D, Monia BP, MacLeod AR (2011) Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding. Blood 118:5302–5311
Ruggeri ZM (2002) Platelets in atherothrombosis. Nat Med 8:1227–1234
Rukoyatkina N, Walter U, Friebe A, Gambaryan S (2011) Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase. Thromb Haemost 106:922–933
Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C, Coughlin SR (2000) Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem 275:6819–6823
Schaff M, Tang C, Maurer E, Bourdon C, Receveru N, Eckly A, Hechler B, Arnold C, de Arcangelis A, Nieswandt B, Denis CV, Lefebvre O, Georges-Labouesse E, Gachet C, Lanza F, Mangin PH (2013) Integrin α6β1 is the main receptor for vascular laminins and plays a role in platelet adhesion, activation, and arterial thrombosis. Circulation 128:541–552
Schoenwaelder SM, Ono A, Nesbitt WS, Lim J, Jarman K, Jackson SP (2010) Phosphoinositide 3-kinase p110β regulates integrin αIIbβ3 avidity and the cellular transmission of contractile forces. J Biol Chem 285:2886–2896
Schwertz H, Tolley ND, Foulks JM, Denis MM, Risenmay BW, Buerke M, Tilley RE, Rondina MT, Harris EM, Kraiss LW, Mackman N, Zimmerman GA, Weyrich AS (2006) Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med 203:2433–2440
Sharda A, Kim SH, Jasuja R, Gopal S, Frlaumenhaft R, Furie BC, Furie B (2015) Defective PDI release from platelets and endothelial cells impairs thrombus formation in Hermansky-Pudlak syndrome. Blood 125:1633–1642
Shattil SJ, Kim C, Ginsberg MH (2010) The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol 11:288–300
Shida Y, Rydz N, Stegner D, Brown C, Mewburn J, Sponagle K, Danisment O, Crawford B, Vidal B, Hegadorn CA, Pruss CM, Nieswandt B, Lillicrap D (2014) Analysis of the role of von Willebrand factor, platelet glycoprotein VI- and α2β1-mediated collagen binding in thrombus formation. Blood 124:1799–1807
Siljander PR, Munnix IC, Smethurst PA, Deckmyn H, Lindhout T, Ouwehand WH, Farndale RW, Heemskerk JW (2004) Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood 103:1333–1341
Smith SA, Choi SH, Davis-Harrison R, Huyck J, Boettcher J, Reinstra CM, Morrissey JH (2010) Polyphosphate exerts differential effects on blood clotting, depending on the polymer size. Blood 116:4353–4359
Stalker TJ, Wu J, Morgans A, Traxler EA, Wang L, Chatterjee MS, Lee D, Quertermouse T, Hall RA, Hammer DA, Diamond SL, Brass LF (2009) Endothelial cell specific adhesion molecule (ESAM) localizes to platelet-platelet contacts and regulates thrombus formation in vivo. J Thromb Haemost 7:1886–1896
Stalker TJ, Welsh JD, Tomaiuolo M, Wu J, Colace TV, Diamond SL, Brass LF (2014) A systems approach to hemostasis: 3. Thrombus consolidation regulates intrathrombus transport and local thrombin activity. Blood 124:1824–1831
Suzuki J, Umeda M, Sims PJ, Nagata S (2010) Calcium-dependent phospholipid scrambling by TMEM16F. Nature 468:834–838
Swieringa F, Kuijpers MJ, Heemskerk JW, van der Meijden PE (2014) Targeting platelet receptor function in thrombus formation: the risk of bleeding. Blood Rev 28:9–21
Swieringa F, Kuijpers MJ, Lamers MM, van der Meijden PE, Heemskerk JW (2015) Rate-limiting roles of tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow. Haematologica 100:748–756
Swieringa F, Baaten CC, Mastenbroek T, Rijnveld N, van der Laan K, Collins P, Lancé MD, Henskens Y, Cosemans JM, Verdoold R, Heemkerk JW, van der Meijden PE (2016) Platelet-dependent control of fibrin distribution and micro-elasticity in thrombus formation under flow. Arterioscler Thromb Vasc Biol 36:692–699
Szasz R, Dale GL (2002) Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT platelets. Blood 100(8):2827–2831
Trivedi V, Boire A, Tchernychev B, Kaneider NC, Leger AJ, O’Callaghan K, Covic L, Kuliopulos A (2009) Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic site. Cell 137:332–343
Vaiyapuri S, Jones CI, Sasikumar P, Moraes LA, Munger SJ, Wright JR, Ali MS, Sage T, Kaiser WJ, Tucker KL, Stain CJ, Bye AP, Jones S, Oviedo-Orta E, Simon AM, Mahaut-Smith MP, Gibbins JM (2012) Gap junctions and connexin hemichannels underpin hemostasis and thrombosis. Circulation 125:2479–2491
Vaiyapuri S, Moraes LA, Sage T, Ali MS, Lewis KR, Mahaut-Smith MP, Iviedo-Orta E, Simon AM, Gibbins JM (2013) Connexin-40 regulates platelet function. Nat Commun 4:2564
Van der Meijden PE, Feijge MA, Giesen PL, Huijberts M, van Raak EP, Heemskerk JW (2005) Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation: a study with healthy subjects and patients at thrombotic risk. Thromb Haemost 93:1128–1137
Van der Meijden PE, Schoenwaelder SM, Cosemans JM, Wetzker R, Heller R, Jackson SP, Heemskerk JW (2008) Dual P2Y12 receptor signaling in thrombin-stimulated platelets: involvement of phosphoinositide 3-kinase β but not γ isoforms in Ca2+ mobilization and procoagulant activity. FEBS J 275:371–385
Van der Meijden PE, Munnix IC, Auger JM, Govers-Riemslag JW, Cosemans JM, Kuijpers MJ, Spronk HM, Watson SP, Renné T, Heemskerk JW (2009) Dual role of collagen in factor XII-dependent thrombus and clot formation. Blood 114:881–890
Van der Meijden PE, Feijge MA, Swieringa F, Gilio K, Nergiz-Unal R, Hamulyak K, Heemskerk JW (2012) Key role of integrin αIIbβ3 signaling to Syk kinase in tissue factor-induced thrombin generation. Cell Mol Life Sci 69:3481–3492
Van Kruchten R, Mattheij NJ, Saunders C, Feijge MA, Swieringa F, Wolfs JL, Collins PW, Heemskerk JW, Bevers EM (2013) Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activation. Blood 121:1850–1857
Van Montfoort ML, Kuijpers MJ, Knaup VL, Bhanot S, Monia BP, Roelofs JT, Heemskerk JW, Meijers JC (2014) Inhibition of factor XI prevents pathological thrombus formation on acutely ruptured atherosclerotic plaques. Arterioscler Thromb Vasc Biol 34:1668–1673
Vanschoonbeek K, Feijge MA, van Kampen RJ, Kenis H, Hemker HC, Giesen PL, Heemskerk JW (2004) Initiating and potentiating roles of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics. J Thromb Haemost 2:476–484
Versteeg HH, Heemskerk JW, Levi M, Reitsma PS (2013) New fundamentals in hemostasis. Physiol Rev 93:327–358
Von Brühl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorentz M, Khandoga A, Tirniceriu A, Coletti R, Köllnberger M, Byrne RA, Laitinen I, Walch A, Brill A, Pfeiler S, Manukyan D, Braun S, Lange P, Riegger J, Ware J, Eckart A, Haidari S, Rudelius M, Schultz C, Echtler K, Brinkmann V, Schwaiger M, Pressner KT, Wagner DD, Mackman N, Engelmann B, Massberg S (2012) Monocytes, neutrophils and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 209:819–835
Watson SP, Auger JM, McCarty OJ, Pearce AC (2005) GPVI and integrin αIIbβ3 signaling in platelets. J Thromb Haemost 3:1752–1762
Watson SP, Herbert JMJ, Pollitt AY (2010) GPVI and CLEC-2 in hemostasis and vascular integrity. J Thromb Haemost 8:1457–1467
Weeterings C, de Groot PG, Adelmeijer J, Lisman T (2008) The glycoprotein Ib-V-IX complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surface. Blood 112:3227–3233
Weiss HJ (2009) Impaired platelet procoagulant mechanisms in patients with bleeding disorders. Semin Thromb Hemostasis 35:233–241
Weiss HJ, Lages B, Zheng S, Hayward CP (2001) Platelet factor V New York: a defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation. Am J Hematol 66:130–139
Weitz JL, Hudoba M, Massel D, Maraganore J, Hirsh J (1990) Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 86–91:385
Welsh JD, Colace TV, Muthard RW, Stalker TJ, Brass LF, Diamond SL (2012) Platelet-targeting sensor reveals thrombin gradient within blood clots forming in microfluidic assay in mouse. J Thromb Haemost 10:2344–2353
White-Adams TC, Berny MA, Tucker EI, Gertz JM, Gailani D, Urbanus RT, de Groot PG, Gruber A, McCarty OJ (2009) Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2). Arterioscler Thromb Vasc Biol 29:1602–1607
Whyte CS, Swieringa F, Mastenbroek TG, Lionikiene AS, Lancé MD, van der Meijden PE, Heemskerk JW, Mutch NJ (2015) Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow. Blood 125:2568–2578
Wood JP, Bunce MW, Maroney SA, Tracy PB, Camire RM, Mast AE (2013) Tissue factor pathway inhibitor-α inhibits prothrombinase during the initiation of blood coagulation. Proc Natl Acad Sci U S A 110:17838–17843
Zwaal RF, Schroit AJ (1997) Pathophysiological implications of membrane phospholipid asymmetry in blood cells. Blood 89:1121–1132
Acknowledgments
The authors acknowledge grant supports from the Landsteiner Foundation for Transfusion Research, the Netherlands Heart Foundation, the Cardiovascular Center Maastricht, and the associated EHA/ISTH board.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Heemskerk, J.W.M., Cosemans, J.M.E.M., van der Meijden, P.E.J. (2017). Platelets and Coagulation. In: Gresele, P., Kleiman, N., Lopez, J., Page, C. (eds) Platelets in Thrombotic and Non-Thrombotic Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-47462-5_32
Download citation
DOI: https://doi.org/10.1007/978-3-319-47462-5_32
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-47460-1
Online ISBN: 978-3-319-47462-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)